Cancer Communications
indexed by SCI
BMC

Important notice

 

 

We would like to inform you that Chinese Journal of Cancer has changed the title to Cancer Communications on 1st March 2018.
Cancer Communications is published by Wiley from 1 January 2020. The journal website is available at: https://onlinelibrary.wiley.com/journal/25233548

 

 

Cancer Communications 最新影响因子突破5分

Cancer Communications (CJC) 获评“2019中国最具国际影响力学术期刊”


A phase I study of toripalimab, an anti‐PD‐1 antibody, in patients with refractory malignant solid tumors
Xiao‐Li Wei, Chao Ren, Feng‐Hua Wang, Yang Zhang, Hong‐Yun Zhao, Ben‐Yan Zou, Zhi‐Qiang Wang, Miao‐Zhen Qiu, Dong‐Sheng Zhang, Hui‐Yan Luo, Feng Wang, Sheng Yao, Rui‐Hua Xu
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/26/2020   doi:10.1002/cac2.12068
A nomogram for predicting overall survival in patients with low‐grade endometrial stromal sarcoma: A population‐based analysis
Jie Wu, Huibo Zhang, Lan Li, Mengxue Hu, Liang Chen, Bin Xu, Qibin Song
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/18/2020   doi:10.1002/cac2.12067
A safe and effective surgical navigation technique in laparoscopic radical gastrectomy: Indocyanine green‐mediated near‐infrared fluorescent imaging
Yan Qian, Shirong Cai
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/11/2020   doi:10.1002/cac2.12033
Modulating the Function of ABCB1: In Vitro and in Vivo Characterization of Sitravatinib, a Tyrosine Kinase Inhibitor
Yuqi Yang, Ning Ji, Chao-Yun Cai, Jing-Quan Wang, Zi-Ning Lei, Qiu-Xu Teng, Zhuo-Xun Wu, Qingbin Cui, Yihang Pan, Zhe-Sheng Chen
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/11/2020   doi:10.1002/cac2.12040
A new mouse esophageal cancer cell line (mEC25)-derived pre-clinical syngeneic tumor model for immunotherapy.
Tuxiong Huang, Jiao Yang, Beilei Liu, Li Fu
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/8/2020   doi:10.1002/cac2.12066
BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T-cell lymphoblastic lymphoma
Xiao‐Peng Tian, Jun Cai, Shu‐Yun Ma, Yu Fang, Hui‐Qiang Huang, Tong‐Yu Lin, Hui‐Lan Rao, Mei Li, Zhong‐Jun Xia, Tie‐Bang Kang, Dan Xie, Qing‐Qing Cai
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 5/27/2020   doi:10.1002/cac2.12039
Treatment and prognosis of iliac fossa soft tissue sarcoma: A single-center study
Wei Sun, Hongqiang, Zhang Biqiang Zheng, Ruming Zhang, Chunmeng Wang, Wangjun Yan, Bing Wang, Xinglong Qu, Yong Chen
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 5/27/2020   doi:10.1002/cac2.12028
Exhaled breath diagnostics of lung and gastric cancers in China using nanosensors
Alaa Gharra, Yoav Y. Broza, Guiping Yu, Weidong Mao, Dong Shen, Lichun Deng, Chun Wu, Qiong Wang, Xia Sun, Jianming Huang, Zhuoqi Xuan, Bing Huang, Song Wu, Yana Milyutin, Viki Kloper‐Weidenfeld, Hossam Haick
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 5/27/2020   doi:10.1002/cac2.12030
Significance of long non‐coding RNA AGPG for the metabolism of esophageal cancer
Rebecca Elizabeth Vargas, Wenqi Wang
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 5/25/2020   doi:10.1002/cac2.12035
Clinical spectrum and prognostic value of TP53 mutations in circulating tumor DNA from breast cancer patients in China
Zongbi Yi, Fei Ma, Guohua Rong, Yanfang Guan, Chunxiao Li, Binghe Xu
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 5/21/2020   doi:10.1002/cac2.12032

more papers...






Gastric cancer  

 

Edited by Yun Dai and Li Yan
 

This thematic series discusses the molecular classifications of gastric cancer by the Cancer Genome Atlas (TCGA) and the Asian Cancer Research Group (ACRG) as well as the implications in personalized therapeutic choices; discusses the evolution of gastric surgery and presents perspectives on surgical techniques in treating gastric cancer; and reviews current and emerging targeted agents as well as immunotherapies in treating gastric cancer. With these advancements in molecular characterization, surgical intervention, and targeted and immunotherapies, gastric cancer will enter a personalized medicine era in the next 5 years.

 

Read thematic series > 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

Tumor angiogenesis  

 

Edited by Francesco Pezzella
and Chao-Nan Qian 

Forming efficient vasculature network, also known as tumor angiogenesis, is a critical hallmark in tumor development. Explorations on its underlying molecular mechanisms have resulted in several novel anti-cancer drugs. However, the modest survival benefits from anti-angiogenic therapy have forced us to revisit our understanding on tumor angiogenesis. In this special issue, world-leading experts have contributed their critical thoughts to reveal alternative tumor angiogenesis approaches and potential treatment targets.

 

Read thematic series > 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

Lung cancer 


 

Edited by Lin Yan and Wei Zhang  

 

Lung cancer accounts for approximately 21% of worldwide cancer deaths and a staggering 1.6 million new cases are diagnosed every year. In China, lung cancer has become a particularly challenging disease because of air pollution and smoking. This thematic series discusses the proper use of targeted agents in treating lung cancer, reviews the application of biomarkers in clinical management and drug development, and analyzes the unique challenges in developing novel drugs for lung cancer in China.

 

Read thematic series > 



CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East,Guangzhou 510060, P.R.China